Back to Results
First PageMeta Content
SEC filings / Corporate finance / Tender offer / Schedule 13D / Cleary Gottlieb Steen & Hamilton / Insider trading / Hart–Scott–Rodino Antitrust Improvements Act / Williams Act / Allergan / Financial economics / Economics / Finance


April 24, 2014 clearygottlieb.com The Schedule 13D Ten-Day Window and Other Issues: Will the Pershing Square/Valeant Accumulation of a 9.7%
Add to Reading List

Document Date: 2014-04-24 15:07:16

Open Document

File Size: 40,02 KB

Share Result on Facebook

City

Moscow / New York / Frankfurt am Main / PARIS / Rome / Cologne / Seoul / BEIJING / Milan / WASHINGTON / Brussels / Buenos Aires / /

Company

Hamilton LLC / Valeant Pharmaceuticals / Cleary Gottlieb Steen & Hamilton LLP / Allergan Lead / /

Country

Germany / Italy / Belgium / France / Russia / Korea / United Kingdom / China / Argentina / /

Event

Reorganization / M&A / /

Facility

Hamilton LLC Paveletskaya Square / Al Sila Tower / Office Locations NEW YORK MILAN One Liberty Plaza / Piazza di Spagna / Pershing Square / Twin Towers / Floor Sowwah Square / /

/

Organization

U.S. Securities and Exchange Commission / Congress / /

Person

Wai Da Jie / /

/

Position

counsel / Foreign Legal Consultant Office / /

ProvinceOrState

New York / /

URL

http /

SocialTag